期刊名称：ONCOLOGY RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Oncology Research
|
Oncology Research Incorporating Anti-Cancer Drug Design publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens. |
 |
Instructions to Authors
American Office: Professor Alan C. Sartorelli, Publication Office, Oncology Research, 149 West Lakeshore Drive, Lake Carmel, NY 10512, USA. Tel: (845) 228-0399; Fax: (845) 228-0394
European Office: Professor Stephen Neidle, Cancer Research UK Biomolecular Structure Group, School of Pharmacy, University of London, 29/39 Brunswick Square, London, WC1N 1AX, UK. Tel: 207 753-5969; Fax: 207 753-5970
Asian Office (for submissions from Asian countries): Professor Takashi Tsuruo, Laboratory of Biomedical Research, Institute of Molecular & Cellular Biosciences, University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113 0032, Japan. Tel: +81-3-5841-8488, Fax: +81-3-5841-8487
Types of Contributions: The Journal publishes full-length papers and short communications, in English, describing the results of original experiments in basic and clinical cancer research. Commentaries, short research editorials of between 3,000 and 5,000 words in length (12-20 typewritten pages, double-spaced) are also published. These are editorial statements intended to stimulate thought on selected topics and should not be exhaustive reviews. They can be controversial and can focus on areas subject to much activity, or draw attention to relatively neglected fields in which there are both opportunities and the need for research. Authors may present personal views on the state of the subject on which they are reporting, and give their view as to where in the near or distant future the subject may be moving. Authors are encouraged to take issue with popular dogmas. Manuscripts are published in the shortest time possible commensurate with scientific quality.
Preparation of Manuscripts: Manuscripts should be submitted in quadruplicate. A cover letter should accompany the manuscript, in which the authors certify that the work submitted to Oncology ResearchIncorporating Anti-Cancer Drug Design has not been published elsewhere in any form, and that it is not being submitted simultaneously to another journal.
The Editors welcome submission by the authors of the names, addresses, phone and Fax numbers of five or six individuals who in their opinion could expertly review their submitted manuscript. The Editors, of course, reserve the right to use reviewers of their choice.
Copyright: Upon acceptance of a manuscript for publication, the author is asked to sign an agreement transferring copyright to the publisher. No published materials may be reproduced or published elsewhere without the written permission of the publisher and the author.
Title Page: List as follows: the title of the manuscript; a running title of less than 60 characters; the authors' full names with middle initials; the address where the work was done; the name, courier address, telephone and Fax number(s), and E-mail address of the corresponding author; and up to six key words for indexing.
Rest of the Manuscript: Abstract (250 words), Introduction, Materials & Methods, Results, Discussion, Acknowledgments and source of funding, References, Tables, Figure legends (together, and separate from the figures), and Figures (each on a separate page). Number all pages. Use generic names of drugs. Give name, city and state, and country of the manufacturer of any chemicals, equipment, or software mentioned in the text. Define and list all nonstandard abbreviations in a footnote to the first abbreviation used in the manuscript (after the abstract).
Computer Disk: To speed publication and ensure accuracy, authors are requested to submit a computer disk containing the final version of their manuscript along with two paper copies of the final manuscript to the editorial office. Please observe the following criteria:
1. Specify what software was used, including which release (e.g., Microsoft Word 97), and what computer was used. 2. Include both text file and ASCII (DOS) file on the disk. 3. The file should be single spaced and should use wrap around end of line feature (i.e., no return at the end of the line). All textual elements should begin flush left, no paragraph indents. Place two returns after every element, such as title, heading, paragraphs, etc. 4. Keep a back-up disk for reference and safety.
Figures: Label line drawings and photographs in pencil on the back with the number and the author's name; indicate which side is the top. Cite figures sequentially in the text. Provide professional quality black-and-white line drawings.
Tables: Cite each table sequentially in the text. Type each table double-spaced on a separate sheet of paper; include a title and, in a footnote, definitions of all abbreviations used (indicated by lowercase superscript letters). Each table and column therein requires an explanatory heading, with units of measure clearly defined.
Figures and tables plus their legends must be interpretable without reference to the text.
Photographs: Continuous-tone, glossy photographs are required. Colored photographs will be published at the author's expense. Send four copies of each photograph.
Citations: Within the text, references should be cited with sequential numbers in parentheses.
Reference List: At the end of the manuscript text, list the references sequentially by number in order of appearance in the text. Follow the style of the examples given below. References must be obtainable in a library to be listed. Reference material not available in a library should be footnoted in the text.
1. Moskowitz, N. K.; Borao, F. J.; Dardashti, O.; Cohen, H. D.; Germino, F. J. The amino terminus of cdk2 binds p21. Oncol. Res. 8:348-352; 1996.
1. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
1. Den Otter, E.; Dullens Hub, F. J.; Van Govern, H.; Pels, E. Antitumor effects of macrophages injected into animals: A review. In: MacBride, J. K.; Stuart, A., eds. The macrophage and cancer. Edinburgh: Econoprint; 1987:119-141.
Footnotes: a) The address of the corresponding author should be footnoted to the author's name under the title; b) Definitions of all nonstandard abbreviations used in the text should be footnoted to the first abbreviation in the text after the abstract, and listed on the title page or separate sheet after the title page; c) Reference to a manuscript (with title and authors noted) that has been submitted for publication elsewhere should be footnoted to the relevant text rather than included in the reference list; d) Personal communications should be footnoted to the relevant text. Limit notes (c) and (d) to two per manuscript.
Personal Communications: A personal communication is an informal exchange of information that is substantiated by a written letter from the source, indicating that the communication cited is correct, original, and recent, and that the source is willing to have the author refer to it, with attribution. Send the letter to the Journal office.
Absolute Values: Wherever percentages are used in Tables or Figures, the absolute values for 100% must be presented in footnotes and in legends, respectively.
Enzymes: The Journal requires full enzyme names and Enzyme Commission (EC) numbers for all enzymes at their first mention and in the abstract.
Isotope Numbers: Place the number before the atomic symbol (e.g., [14C]); if the position of a label is given, it should be placed in brackets before the symbol of the element (e.g., [1-14C]alanine). Follow the American Chemical Society conventions for isotope nomenclature and designations.
Symbols and Units: Follow the International System of Units (SI).
Nomenclature: Authors should use SI units and follow the guidelines for abbreviations and symbols of the IUPAC-IUB Joint Commission on Biochemical Nomenclature. See Eur. J. Biochem. 25:1-4; 1972. For bases in nucleic acid sequences, see Eur. J. Biochem. 150:1-54; 1985.
Trade Marks and Registered Compounds: Indicate, by the appropriate symbols, those compounds and equipment that by law are still under patent and require TM or ?/SUP> next to the name.
Statistics: Provide the number of experiments done, the mean, and some measure of variation; provide degrees of freedom plus the probability that the value would have occurred by chance for t-tests and nonparametric tests. Reserve ``significant'' for statistical significance.
Do not apply t-tests to percentages; apply them to the raw data. Determinations done should indicate the number of replicates in one experiment and are not used for statistical analyses per se but only to obtain the mean in an experiment.
Editorial Board
Co-Editor-in-Chief
Alan C. Sartorelli, Yale University School of Medicine
European Co-Editor-in-Chief
Stephen Neidle, University of London
Asian Co-Editor-in-Chief
Takashi Tusruo, University of Tokyo
EDITORIAL ADVISORY BOARD
American Continent: Alan C. Sartorelli, Co-Editor-in-Chief
K. W. Bair, Pharmacia Corporation, New Jersey, USA
J. R. Bertino, Cancer Institute of New Jersey, USA
R. A. Bradshaw, University of California, Irvine, USA
Y.-C. Cheng, Yale University School of Medicine, USA
R. L. Erikson, Harvard University, USA
W. N. Hait, Cancer Institute of New Jersey, USA
S. M. Hecht, University of Virginia, USA
L. H. Hurley, Arizona Cancer Center, Tucson, USA
P. A. Jones, University of Southern California, USA
J. S. Lazo, University of Pittsburgh School of Medicine, USA
G. Litwack, Jefferson Cancer Institute, Philadelphia, PA, USA
J. W. Lown, University of Alberta, Canada
L. A. Loeb, University of Washington, USA
S. Pestka, UMDNJ-Robert Wood Johnson Medical School, USA
G. R. Pettit, Cancer Research Institute, Arizona, USA
Y. G. Pommier, National Cancer Institute, Bethesda, MD, USA
G. Powis, Arizona Cancer Center, USA
M. Reiss, Cancer Institute of New Jersey, USA
J. Siegfried, University of Pittsburgh School of Medicine, USA
E. J. Stanbridge, University of California, Irvine, USA
C. Stein, Columbia University College of Physicians and Surgeons, USA
European Continent: Stephen Neidle, Co-Editor-in-Chief
C. Bailly, Institute de Recherch¨¦s sur le Cancer de Lille, France
M. Beato, Philipps-Universität, Germany
A. H. Calvert, University of Newcastle upon Tyne, United Kingdom
M. D'Incalei, Institute de Ricerche Farmacologiche, Italy
W. Fiers, University of Ghent, Belgium
L. Frati, University of Rome, Italy
D. Givol, The Weizmann Institute of Science, Israel
R. L. Harris, Churchill Hospital, United Kingdom
J. Hartley, University College London Medical School, United Kingdom
C. Helene, Muséum National d'Histoire Naturelle, Paris, France
A. Levitzki, Hebrew University of Jerusalem, Israel
M. F. Rajewsky, Universität Essen, Germany
D. Shugar, Academy of Sciences, Poland
M. F. G. Stevens, University of Nottingham, United Kingdom
D. Thurston, University of London, United Kingdom
A. S. Tsiftsoglou, Aristotle University of Thessaloniki, Greece
G. Vecchio, Universit?Degli Studi di Napoli Federico II, Italy
M. J. Waring, University of Cambridge, United Kingdom
P. Workman, CRC Center for Cancer Therapeutics, United Kingdom
Asia and Pacific Rim: Takashi Tusruo, Co-Editor-in-Chief
Y.-J. Bang, SNU Cancer Research Institute, Korea
B. C. Baguley, Auckland Cancer Society Research Center, New Zealand
A.-Y. Chang, National University Hospital, Singapore
M. K. Chang, National Cancer Center, Korea
W. A. Denny, University of Auckland, New Zealand
T. Irimura, University of Tokyo, Japan
K. Kohno, University of Occupational & Environmental Health, Kitakyushu, Japan
J.-K. Lin, National Taiwan University, Republic of China
Y. Maehara, Kyushu University, Japan
A. Matsuda, Hokkaido University, Japan
K. Miyazaki, Yokohama University, Japan
I. Saiki, Toyama Medical and Pharmaceutical University, Japan
T. Sakai, Kyoto Prefectural University of Medicine, Japan
Y. Satoh, Tohoku University, Japan
C. Shou, Beijing Institute for Cancer Research, China
J.-G. Song, Chinese Academy of Sciences, China
K. Umezawa, Keio University, Japan
|
刊名字顺( Alphabetical List of Journals):
返回页首 